FREQUENCY THERAPEUTICS INC (FREQ) Stock Analyst Earnings Estimates
NASDAQ:FREQ - Nasdaq - US35803L1089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.95M | 36.98M 27.74% | 14.068M -61.96% | -100.00% | 115.32M | 198.72M 72.32% | 294.66M 48.28% | ||||||
| EBITDA YoY % growth | -19.87M -8.64% | -26.4M -32.86% | -81.256M -207.79% | -85.974M 1.26% | -76.079M 5.18% | -85.564M -12.47% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20.68M -9.19% | -27.55M -33.22% | -84.031M -205.01% | -88.927M 1.22% | -58.116M 29.98% | -44.979M 22.60% | -58.65M -30.39% | -63.75M -8.70% | -68.85M -8.00% | -73.76M -7.13% | -12.833M 82.60% | 67.793M 628.29% | |
| Operating Margin | -71.43% | -74.50% | -597.32% | N/A | N/A | N/A | N/A | N/A | N/A | -63.96% | -6.46% | 23.01% | |
| EPS YoY % growth | N/A | -0.81 19.05% | -2.47 -204.94% | -2.50 6.07% | -1.58 31.85% | -1.16 26.32% | -1.28 -9.46% | -1.07 16.00% | -1.07 | 0.02 101.90% | 0.16 700.00% | 0.32 93.75% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 34.26% | -0.29 39.84% | -0.23 57.35% | -0.21 28.60% | -0.20 43.58% | -0.20 30.80% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.919M 36.28% | -10.598M 41.76% | -8.454M 58.78% | -8.461M 39.04% | -8.468M 34.45% | -8.476M 20.02% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.30 50.82% | -0.36 | 0.06 | 17.21% |
| Q1 2023 Q2Q % growth | -0.55 17.91% | -0.43 | -0.12 | -28.23% |
| Q4 2022 Q2Q % growth | -0.49 20.97% | -0.64 | 0.15 | 23.84% |
| Q3 2022 Q2Q % growth | -0.55 24.66% | -0.58 | 0.03 | 5.28% |
| Q2 2022 Q2Q % growth | -0.61 -17.31% | -0.69 | 0.08 | 11.14% |
| Q1 2022 Q2Q % growth | -0.67 -11.67% | -0.65 | -0.02 | -3.44% |
| Q4 2021 Q2Q % growth | -0.62 -106.67% | 0.16 | -0.78 | -498.85% |
| Q3 2021 Q2Q % growth | -0.73 -356.25% | -0.59 | -0.14 | -24.68% |
| Q2 2021 Q2Q % growth | -0.52 -173.68% | -0.52 | 0.00 | -0.28% |
| Q1 2021 Q2Q % growth | -0.60 -275.00% | -0.28 | -0.32 | -112.61% |
| Q4 2020 Q2Q % growth | -0.30 -57.89% | -0.26 | -0.04 | -15.52% |
| Q3 2020 Q2Q % growth | -0.16 78.08% | -0.28 | 0.12 | 43.73% |
| Q2 2020 Q2Q % growth | -0.19 | -0.19 | 0.00 | -1.10% |
| Q1 2020 Q2Q % growth | -0.16 | -0.18 | 0.02 | 9.33% |
| Q4 2019 Q2Q % growth | -0.19 | 0.10 | -0.29 | -283.52% |
| Q3 2019 Q2Q % growth | -0.73 | -0.69 | -0.04 | -5.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | 3.315M | -3.315M | -100.00% | |
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | 31.62M | -31.62M | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 2.426M | -2.426M | -100.00% |
| Q2 2021 Q2Q % growth | 9.417M 10.53% | 6.843M | 2.574M | 37.62% |
| Q1 2021 Q2Q % growth | 4.65M -35.95% | 8.289M | -3.639M | -43.90% |
| Q4 2020 Q2Q % growth | 9.95M 111.25% | 8.516M | 1.434M | 16.84% |
| Q3 2020 Q2Q % growth | 11.25M -53.59% | 5.998M | 5.252M | 87.56% |
| Q2 2020 Q2Q % growth | 8.52M | 6.268M | 2.252M | 35.93% |
| Q1 2020 Q2Q % growth | 7.26M | 5.977M | 1.283M | 21.47% |
| Q4 2019 Q2Q % growth | 4.71M | 12.822M | -8.112M | -63.27% |
| Q3 2019 Q2Q % growth | 24.24M | 40.8M | -16.56M | -40.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -2.99% | 3.56% |
| Revenue | N/A | N/A | N/A | N/A |